Search

Search Results
Results 1031 - 1040 of 1137 for Diabetes Type II
  • Redesigning obesity trials for a chronic disease era
    White Paper - 17 Apr 2026
    Obesity trials are evolving toward chronic disease models with improved endpoints, longer study designs, and greater clinical relevance.
  • Rethinking early-phase MASLD trials
    White Paper - 17 Apr 2026
    Explore new approaches to early-phase MASLD trials, addressing metabolic complexity and improving clinical relevance in study design.
  • Clopidogrel Winthrop
    Drug - 16 Apr 2026
    Consumer Medicine Information (CMI) about Clopidogrel Winthrop intended for persons living in Australia.
  • Clopidogrel Winthrop Plus Aspirin
    Drug - 16 Apr 2026
    Consumer Medicine Information (CMI) about Clopidogrel Winthrop Plus Aspirin intended for persons living in Australia.
  • DuoCover
    Drug - 10 Apr 2026
    Consumer Medicine Information (CMI) about DuoCover intended for persons living in Australia.
  • Velsipity
    Drug - 26 Mar 2026
    Consumer Medicine Information (CMI) about Velsipity intended for persons living in Australia.
  • Nextstellis
    Drug - 5 Mar 2026
    Consumer Medicine Information (CMI) about Nextstellis intended for persons living in Australia.
  • Prezcobix
    Drug - 27 Feb 2026
    Consumer Medicine Information (CMI) about Prezcobix intended for persons living in Australia.
  • Symtuza
    Drug - 19 Jan 2026
    Consumer Medicine Information (CMI) about Symtuza intended for persons living in Australia.
  • Dilart HCT
    Drug - 15 Dec 2025
    Consumer Medicine Information (CMI) about Dilart HCT intended for persons living in Australia.

Terms

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

Provide Feedback